|
FR2556219B1
(fr)
|
1983-12-07 |
1987-06-26 |
Merieux Inst |
Nouveau medicament immunomodulateur, a base de fragments fc d'igg humaines
|
|
US5426641A
(en)
|
1994-01-28 |
1995-06-20 |
Bell Communications Research, Inc. |
Adaptive class AB amplifier for TDMA wireless communications systems
|
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
|
JP2000515731A
(ja)
|
1996-06-14 |
2000-11-28 |
スミスクライン・ビーチャム・コーポレイション |
６量体融合タンパク質およびその使用
|
|
US20090074839A1
(en)
|
1997-01-22 |
2009-03-19 |
Marton Milankovits |
Pharmaceutical Compositions Primarily for the Treatment and Prevention of Genitourinary Infections and their Extragenital Complications
|
|
US7951917B1
(en)
|
1997-05-02 |
2011-05-31 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
CA2921260A1
(en)
|
1999-12-24 |
2001-06-28 |
Genentech, Inc. |
Methods and compositions for prolonging elimination half-times of bioactive compounds
|
|
US20050089932A1
(en)
|
2001-04-26 |
2005-04-28 |
Avidia Research Institute |
Novel proteins with targeted binding
|
|
WO2005077981A2
(en)
|
2003-12-22 |
2005-08-25 |
Xencor, Inc. |
Fc POLYPEPTIDES WITH NOVEL Fc LIGAND BINDING SITES
|
|
JP5620626B2
(ja)
|
2005-03-31 |
2014-11-05 |
中外製薬株式会社 |
会合制御によるポリペプチド製造方法
|
|
GB0614780D0
(en)
|
2006-07-25 |
2006-09-06 |
Ucb Sa |
Biological products
|
|
AU2007343796A1
(en)
|
2006-10-25 |
2008-07-24 |
Amgen Inc. |
Toxin peptide therapeutic agents
|
|
BRPI0620639A2
(pt)
|
2006-12-21 |
2011-11-22 |
Micromet Ag |
anticorpos de cadeia simples biespecìficos e composição farmacêutica compreendendo os mesmos
|
|
US20080260738A1
(en)
|
2007-04-18 |
2008-10-23 |
Moore Margaret D |
Single chain fc, methods of making and methods of treatment
|
|
MX2009012343A
(es)
|
2007-05-14 |
2010-02-10 |
Biogen Idec Inc |
Regiones fc (sc fc) de cadena sencilla, polipeptidos de enlace que comprenden las mismas, y metodos relacionados con ello.
|
|
KR101580937B1
(ko)
|
2007-06-01 |
2015-12-31 |
유니버시티 오브 매릴랜드, 발티모어 |
면역글로불린 불변영역 Ｆｃ 수용체 결합제
|
|
PT2235064E
(pt)
|
2008-01-07 |
2016-03-01 |
Amgen Inc |
Método de preparação de moléculas heterodiméricas de fc de anticorpos utilizando efeitos de indução eletrostática
|
|
CA2720368C
(en)
|
2008-04-02 |
2017-08-22 |
Macrogenics, Inc. |
Her2/neu-specific antibodies and methods of using same
|
|
AU2009302582A1
(en)
|
2008-10-06 |
2010-04-15 |
University Of Chicago |
Compositions and methods related to bacterial Eap, Emp, and/or AdsA proteins
|
|
WO2010065578A2
(en)
|
2008-12-04 |
2010-06-10 |
Leukosight Inc. |
POLYPEPTIDES COMPRISING Fc FRAGMENTS OF IMMUNOGLOBULIN G (IgG) AND METHODS OF USING THE SAME
|
|
CA2747011C
(en)
|
2008-12-18 |
2018-06-19 |
Dana-Farber Cancer Institute, Inc. |
Nkg2d-fc for immunotherapy
|
|
JP2012515556A
(ja)
|
2009-01-23 |
2012-07-12 |
バイオジェン・アイデック・エムエイ・インコーポレイテッド |
低下したエフェクタ機能を有する安定化Ｆｃポリペプチドおよび使用方法
|
|
AU2010249787A1
(en)
|
2009-05-20 |
2011-12-22 |
Theraclone Sciences, Inc. |
Compositions and methods for the therapy and diagnosis of influenza
|
|
EP2432451A2
(en)
|
2009-05-20 |
2012-03-28 |
Children's Medical Center Corporation |
Compositions for the treatment of metastatic cancer and methods of use thereof
|
|
JP5683581B2
(ja)
|
2009-06-30 |
2015-03-11 |
リサーチ ディベロップメント ファウンデーション |
免疫グロブリンＦｃポリペプチド
|
|
JP6091894B2
(ja)
|
2009-09-16 |
2017-03-15 |
ジェネンテック， インコーポレイテッド |
コイルドコイルおよび／またはテザー含有タンパク質複合体およびその使用
|
|
BR112012007760A2
(pt)
|
2009-10-07 |
2015-08-25 |
Macrogenics Inc |
Método de atenuar fucosilação pós translacional de uma região fc de igc humana, anticorpo que se liga especificamente a um antigeno de câncer caracteristico de um cancêr polipeptideo
|
|
ES2688978T3
(es)
|
2009-11-23 |
2018-11-07 |
Amgen Inc. |
Anticuerpo monomérico Fc
|
|
GB0922209D0
(en)
|
2009-12-18 |
2010-02-03 |
Univ Nottingham |
Proteins, nucleic acid molecules and compositions
|
|
ES2674567T3
(es)
|
2010-05-21 |
2018-07-02 |
Merrimack Pharmaceuticals, Inc. |
Proteínas de fusión biespecíficas
|
|
EA201291482A1
(ru)
|
2010-07-09 |
2013-10-30 |
Байоджен Айдек Хемофилия Инк. |
Химерные факторы коагуляции
|
|
DK2598533T3
(en)
|
2010-07-28 |
2019-04-23 |
Gliknik Inc |
Fusion proteins of natural human protein fragments to create in an orderly fashion multimerized immunoglobulin FC compositions
|
|
JP2013537416A
(ja)
|
2010-08-13 |
2013-10-03 |
メディミューン リミテッド |
変異型Ｆｃ領域を含むモノマーポリペプチド及び使用方法
|
|
ES2758994T3
(es)
|
2010-11-05 |
2020-05-07 |
Zymeworks Inc |
Diseño anticuerpo heterodimérico estable con mutaciones en el dominio Fc
|
|
EP2686348B1
(en)
|
2011-03-17 |
2015-12-30 |
Ramot at Tel-Aviv University Ltd. |
Bi- and monospecific, asymmetric antibodies and methods of generating the same
|
|
AU2012235758B2
(en)
|
2011-03-25 |
2015-05-07 |
IGI Therapeutics SA |
Hetero-dimeric immunoglobulins
|
|
EP4079316A1
(en)
|
2012-06-08 |
2022-10-26 |
Bioverativ Therapeutics Inc. |
Procoagulant compounds
|
|
TW201402611A
(zh)
|
2012-06-21 |
2014-01-16 |
Univ Indiana Res & Tech Corp |
具有改變之ｆｃ效應子功能之腸促胰島素受體配體多肽ｆｃ區融合多肽及結合物
|
|
JP2015527366A
(ja)
*
|
2012-08-20 |
2015-09-17 |
グリックニック インコーポレイテッド |
抗原結合および多価ｆｃガンマ受容体結合活性を有する分子
|
|
CN110894231A
(zh)
|
2012-10-17 |
2020-03-20 |
康诺贝林伦瑙有限公司 |
免疫调节蛋白
|
|
CN104558194B
(zh)
|
2013-10-17 |
2018-04-27 |
泰州迈博太科药业有限公司 |
一类抗CD20-Flex双功能融合蛋白、其制备方法及用途
|
|
WO2015073721A1
(en)
*
|
2013-11-13 |
2015-05-21 |
Zymeworks Inc. |
Monovalent antigen binding constructs targeting egfr and/or her2 and uses thereof
|
|
US10137170B2
(en)
|
2013-12-20 |
2018-11-27 |
Indiana University Research And Technology Corporation |
Lipidated incretin receptor ligand human immunoglobulin Fc-region fusion polypeptides
|
|
EP3094649A1
(en)
*
|
2014-01-15 |
2016-11-23 |
F. Hoffmann-La Roche AG |
Fc-region variants with modified fcrn-binding properties
|
|
RU2727639C2
(ru)
*
|
2014-01-15 |
2020-07-22 |
Ф.Хоффманн-Ля Рош Аг |
Варианты fc-области с модифицированной способностью связываться с fcrn и с сохраненной способностью связываться с белком а
|
|
CN106132994A
(zh)
|
2014-03-05 |
2016-11-16 |
Ucb生物制药私人有限公司 |
多聚体Fc蛋白
|
|
UY36021A
(es)
|
2014-03-05 |
2015-09-30 |
Ucb Biopharma Sprl |
Proteìnas fc multimèricas
|
|
BR112016023948A2
(pt)
|
2014-04-16 |
2018-01-30 |
Ucb Biopharma Sprl |
proteínas fc multiméricas
|
|
SG10201913507SA
(en)
|
2014-05-02 |
2020-02-27 |
Momenta Pharmaceuticals Inc |
Compositions and methods related to engineered fc constructs
|
|
RU2718692C2
(ru)
|
2014-05-29 |
2020-04-13 |
Мэкроудженикс, Инк. |
Триспецифичные связывающие молекулы, которые специфически связывают антигены множества злокачественных опухолей, и способы их применения
|
|
ES2972740T3
(es)
*
|
2016-03-02 |
2024-06-14 |
Momenta Pharmaceuticals Inc |
Procedimientos relacionados con construcciones de Fc modificadas genéticamente
|
|
NZ749292A
(en)
|
2016-05-23 |
2025-08-29 |
Momenta Pharmaceuticals Inc |
Compositions and methods related to engineered fc constructs
|
|
CN110650748B
(zh)
|
2017-01-06 |
2024-01-02 |
动量制药公司 |
与经工程改造的Fc构建体相关的组合物和方法
|